Bicon Pharmaceutical to Invest 2.25 bn Yuan in Expanding LiPF6 Capacity

On the evening of February 21, Bicon Pharmaceutical announced that the company's holding subsidiary, Jiangsu Jijiu Technology will expand its existing 35,000 mt of lithium hexafluorophosphate (LiPF6) capacity.

By adding 35,000 mt of LiPF6 capacity and 10,000 mt of sodium hexafluorophosphate (NaPF6), the company aims to reach an annual production capacity of 50,000 mt of hexafluorophosphate. The project is expected to require an investment of 2.25 billion yuan.